Target intelligence / Profile preview

Puumala virus envelope glycoprotein (Gn/Gc)

Target
Gn/Gc
Molecular classification
Viral surface glycoprotein, Class II fusion protein (specifically for Gc), Envelope protein, Other (for complexes and virion spike assemblies)
01

Overview

The Puumala virus envelope glycoprotein comprises two main structural proteins, Gn and Gc, which are anchored in the viral lipid envelope and display as tetrameric spikes on the virion surface. Gn and Gc are translated as a single polypeptide precursor and cleaved by a signal sequence. Gn is responsible primarily for receptor interaction and spike formation, while Gc acts as a class II membrane fusion effector, mediating the fusion of the viral and host membranes in a pH-dependent manner during endocytosis. Both glycoproteins are essential for hantavirus infectivity, assembly, and budding, and are the principal targets of host neutralizing antibodies. They play central roles in the disease pathogenesis of Puumala virus, which causes nephropathia epidemica (a mild hemorrhagic fever with renal syndrome) in humans, mainly in Europe. No approved drugs directly target Gn or Gc, but they are considered key therapeutic and vaccine candidates due to their extracellular viral surface exposure and essential function in entry and infection.

Other names
Hantavirus Gn and Gc envelope glycoproteinsPuumala virus glycoprotein GnPuumala virus glycoprotein GcG1 and G2 (historical/alternative names; current standard is Gn and Gc)
02

Mechanism of action

Inhibition of membrane fusion (blocks conformational change in Gc required for fusion of the viral and host membranes) Neutralization of virus by antibody binding to spike epitopes (prevents receptor binding or fusion)

03

Biological functions

Membrane fusion (mediated by Gc)Virus entry (attachment, recognition, and fusion with host cell membranes)Spike formation/oligomerization (assembly of virion surface lattice)Interaction with host cell receptors (facilitates endocytosis)Viral assembly and budding (organization of glycoproteins and viral particles)
04

Disease associations

Infection (hantavirus disease, particularly nephropathia epidemica in humans)Zoonotic transmission (infection of humans from rodent reservoirs)
05

Safety considerations

High immunogenicity (can provoke antibody-dependent enhancement or immune complex formation in some contexts)Mutational escape (single amino acid substitutions can abrogate neutralizing antibody binding)No licensed vaccines or widely effective antivirals—therapeutic targeting remains research-stage
06

Interacting drugs

No currently approved direct-acting drugs, but candidate drugs and neutralizing antibodies have been reported.

2 more in the full profile.

07

Biomarkers

Anti-Gn or anti-Gc antibody titers (correlate with past or active infection, or vaccine response)Glycoprotein epitope sequence (for surveillance of immune escape variants)Presence of viral glycoproteins in patient samples (rarely used clinically)

Beyond the preview

Go deeper on Puumala virus envelope glycoprotein (Gn/Gc).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Puumala virus envelope glycoprotein (Gn/Gc).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call